Accenture: My March Fair Value Was Too High. The Stock Is Still Too Cheap

Back in March I published a piece called The Dividend Compounder Trading at a Value Price. It argued that Accenture (ACN) was a $292 business trading near $213, and that the market's AI disruption worry had the story pointed in the wrong direction.

The stock is now ~$172 as of pre-market on August 18th, 2026.

So before anything else, let's start with the scoreboard, because it is not flattering. Shares are down roughly 17% since that article while the broad market rose, and they traded all the way to $118.15 in June.

How wrong was I? I named $204 as the ultra-value zone where a full position gets completed, and I put the downside case at a 5% to 8% loss. Both got run over inside three months.

I'm not going to dress that up as a call we nailed. What I underestimated is how far the market will reprice a genuinely good business once it decides the business model itself is the question.

Here's what I did get right, and it's the only reason this update is worth writing. Before the drawdown started, I wrote down the exact condition that would prove the thesis broken: two consecutive quarters of declining bookings, combined with full-year revenue guidance falling below 2%.

That condition has not been met.

So why cut fair value by 22% and still call it a Strong Buy? Let's get right to it. My updated Vulcan fair value is $227.62, roughly 22% below the old number. Even after that cut, the stock still sits inside the Strong Buy zone with 22.3% margin of safety, and I think the price is asking the business to do something it is not currently doing.